Detalhe da pesquisa
1.
Asthma control in the United States: relationships between short-acting ß2-agonist and systemic corticosteroid use.
Ann Allergy Asthma Immunol
; 2024 May 11.
Artigo
Inglês
| MEDLINE | ID: mdl-38740134
2.
Advancing assessment of asthma control with a composite tool: The Asthma Impairment and Risk Questionnaire.
Ann Allergy Asthma Immunol
; 2024 Mar 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38494113
3.
Assessing meaningful change in the Asthma Impairment and Risk Questionnaire.
Ann Allergy Asthma Immunol
; 2024 Feb 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38369256
4.
Patterns of rescue and maintenance therapy claims surrounding a clinical encounter for an asthma exacerbation.
Ann Allergy Asthma Immunol
; 131(4): 458-465.e1, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37343824
5.
The Asthma Impairment and Risk Questionnaire enhances the assessment of asthma control.
Ann Allergy Asthma Immunol
; 131(4): 436-443.e1, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37105501
6.
Mapping geographic variability of severe uncontrolled asthma in the United States: Management implications.
Ann Allergy Asthma Immunol
; 128(1): 78-88, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34628005
7.
Evaluating construct validity of the Asthma Impairment and Risk Questionnaire using a 3-month exacerbation recall.
Ann Allergy Asthma Immunol
; 128(5): 544-552.e3, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35123077
8.
Real-world patterns and implications of short-acting ß2-agonist use in patients with asthma in the United States.
Ann Allergy Asthma Immunol
; 126(6): 681-689.e1, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33515710
9.
Current practice patterns, challenges, and educational needs of asthma care providers in the United States.
J Asthma
; 58(8): 1118-1127, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32336241
10.
Maintenance inhaler therapy preferences of patients with asthma or chronic obstructive pulmonary disease: a discrete choice experiment.
Thorax
; 75(9): 735-743, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32631932
11.
Efficacy and safety of budesonide/formoterol pMDI vs budesonide pMDI in asthmatic children (6-<12 years).
Ann Allergy Asthma Immunol
; 118(4): 489-499.e1, 2017 04.
Artigo
Inglês
| MEDLINE | ID: mdl-28256307
12.
Impact of Clinical Characteristics and Biomarkers on Asthma Impairment and Risk Questionnaire Exacerbation Prediction Ability.
J Allergy Clin Immunol Pract
; 2024 May 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38705273
13.
A Discrete Choice Experiment to Assess Patient Preferences for Asthma Rescue Therapy and Disease Management.
J Allergy Clin Immunol Pract
; 11(9): 2781-2791.e4, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37182565
14.
Relationship Between Asthma Control as Measured by the Asthma Impairment and Risk Questionnaire (AIRQ) and Patient Perception of Disease Status, Health-Related Quality of Life, and Treatment Adherence.
J Asthma Allergy
; 16: 59-72, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36636702
15.
The use of short-acting bronchodilators and cost burden of asthma across Global Initiative for Asthma-based severity levels: Insights from a large US commercial and managed Medicaid population.
J Manag Care Spec Pharm
; 28(8): 881-891, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35708342
16.
Suboptimal Control of Asthma Among Diverse Patients: A US Mixed Methods Focus Group Study.
J Asthma Allergy
; 15: 1511-1526, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36313858
17.
Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America.
J Allergy Clin Immunol Pract
; 10(9): 2297-2309.e10, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35364341
18.
The Asthma Impairment and Risk Questionnaire (AIRQ) Control Level Predicts Future Risk of Asthma Exacerbations.
J Allergy Clin Immunol Pract
; 10(12): 3204-3212.e2, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-35998877
19.
Association of Nonmedical Switches in Inhaled Respiratory Medications with Disruptions in Care: A Retrospective Prescription Claims Database Analysis.
Pulm Ther
; 7(1): 189-201, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-33713011
20.
Dual-combination maintenance inhaler preferences in asthma and chronic obstructive pulmonary disease: A patient-centered benefit-risk assessment.
Respir Med
; 176: 106278, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33387985